The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Dey Laboratories
Approval Status: Approved October 1998
Treatment for: Pediatric Respiratory Distress Syndrome
General Information
Curosurf is used as a treatment for respiratory distress syndrome in premature infants.